A number of European countries (including Ireland, France, the Netherlands, Sweden and the United Kingdom) indicate an increase seen during 2022, particularly since September 2022, in the number of cases of invasive Group A Streptococcus (iGAS) disease among children less than ten years of age.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 – 10 December 2022 and includes updates on COVID-19, Ebola virus, respiratory syncytial virus, streptococcal infection, diphtheria, seasonal influenza, mpox (monkeypox), hepatitis, MERS-CoV, meningitis, and mass gathering monitoring at the FIFA World Cup 2022 Qatar.
This report presents the results of the ECDC European Reference Laboratory Network for Pertussis (ERLNPert-Net) external quality assessment (EQA) scheme for Bordetella pertussis PCR, funded by ECDC on behalf of ERLNPert-Net and conducted from April to September 2020. The EQA was organised by the National Institute for Biological Standards and Control (NIBSC), based in Potter’s Bar, United Kingdom (UK).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 February 2022, and includes updates on COVID-19, Influenza, polio, cholera, Lassa fever, and mass gathering monitoring for the Winter Olympic Games in Beijing.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 February 2022, and includes updates on COVID-19, Influenza, Lassa fever, mass gathering monitoring for the Winter Olympic Games in Beijing, Chikungunya, and dengue.